The novel angiotensin II type I receptor (ATIR)-associated protein ATRAP downregulates ATIR and ameliorates cardiomyocyte hypertrophy

Activation of angiotensin II (Ang II) type I receptor (AT1R) signaling is reported to play an important role in cardiac hypertrophy. We previously cloned a novel molecule interacting with the AT1R, which we named ATRAP (for Ang II type I receptor-associated protein). Here, we report that overexpression of ATRAP significantly decreases the number of AT1R on the surface of cardiomyocytes, and also decreases the degree of p38 mitogen-activated protein kinase phosphorylation, the activity of the c-fos promoter and protein synthesis upon Ang II treatment. These results indicate that ATRAP significantly promotes downregulation of the AT1R and further attenuates certain Ang II-mediated hypertrophic responses in cardiomyocytes. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.